Department of Pharmacology, College of Korean Medicine, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul, Republic of Korea; Basic Research Laboratory for Comorbidity Regulation, Comorbidity Research Institute, Kyung Hee University, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul, Republic of Korea.
Department of Pharmacology, College of Korean Medicine, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul, Republic of Korea.
Phytomedicine. 2019 Jan;52:254-263. doi: 10.1016/j.phymed.2018.09.227. Epub 2018 Sep 27.
Platycodi Radix (root of Platycodon grandiflorum) and its active compound platycodin D (PD) has been previously shown to possess anti-obesity properties, but the underlying mechanisms remain poorly understood.
The present study was aimed to evaluate the anti-obese effect of PD and reveal its mechanism of action.
STUDY DESIGN/METHODS: Genetically obese db/db mice were orally treated with PD for 4 weeks, and body weight gain, adipose tissue weight, serum parameters were measured. Then, assays on adipogenic factors, thermogenic factors, and AMP-activated protein kinase (AMPK) pathway were performed in PD-treated 3T3-L1 murine adipocytes, human adipose-derived mesenchymal stem cells (hAMSCs), and primary cultured brown adipocytes.
PD treatment attenuated body weight gain, suppressed white adipose tissue weight and improved obesity-related serum parameters in db/db mice. Two major adipogenic factors, peroxisome proliferator-activated receptor gamma (PPARγ) and CCAAT/enhancer binding protein α (C/EBPα) were decreased by PD treatment in WAT of db/db mice, 3T3-L1 adipocytes and hAMSCs. In BAT of db/db mice and primary cultured brown adipocytes, PD treatment elevated the expressions of uncoupled protein 1 (UCP1) and peroxisome proliferator-activated receptor γ coactivator 1 α (PCG1α), the key regulators of BAT-associated thermogenesis. In addition, PD activated AMPKα both in vivo and in vitro. However, when AMPK was inhibited by compound C, PD treatment failed to suppress adipogenic factors and increase thermogenic factors.
PD improved obesity in db/db mice by AMPK-associated decrease of adipogenic markers including PPARγ and C/EBPα. PD increased thermogenic factors such as UCP1 and PGC1α in db/db mice and primary cultured brown adipocytes. AMPK inhibition nullified the effects of PD, suggesting its anti-adipogenic and thermogenic actions were dependent on AMPK pathway activation.
桔梗(桔梗根)及其活性化合物桔梗皂苷 D(PD)先前已被证明具有抗肥胖作用,但作用机制仍不清楚。
本研究旨在评估 PD 的抗肥胖作用,并揭示其作用机制。
研究设计/方法:遗传肥胖 db/db 小鼠经口给予 PD 治疗 4 周,测量体重增加、脂肪组织重量和血清参数。然后,在 PD 处理的 3T3-L1 鼠脂肪细胞、人脂肪间充质干细胞(hAMSCs)和原代培养的棕色脂肪细胞中进行脂肪生成因子、产热因子和 AMP 激活蛋白激酶(AMPK)通路的测定。
PD 治疗可减轻 db/db 小鼠的体重增加,抑制白色脂肪组织重量,并改善肥胖相关的血清参数。两种主要的脂肪生成因子,过氧化物酶体增殖物激活受体γ(PPARγ)和 CCAAT/增强子结合蛋白α(C/EBPα),在 db/db 小鼠的 WAT、3T3-L1 脂肪细胞和 hAMSCs 中被 PD 处理下调。在 db/db 小鼠的 BAT 和原代培养的棕色脂肪细胞中,PD 治疗可提高解偶联蛋白 1(UCP1)和过氧化物酶体增殖物激活受体γ共激活因子 1α(PCG1α)的表达,这是 BAT 相关产热的关键调节因子。此外,PD 在体内和体外均激活 AMPKα。然而,当 AMPK 被化合物 C 抑制时,PD 处理未能抑制脂肪生成因子并增加产热因子。
PD 通过 AMPK 相关的降低包括 PPARγ 和 C/EBPα 在内的脂肪生成标志物来改善 db/db 小鼠的肥胖。PD 增加了 db/db 小鼠和原代培养的棕色脂肪细胞中的产热因子,如 UCP1 和 PGC1α。AMPK 抑制消除了 PD 的作用,表明其抗脂肪生成和产热作用依赖于 AMPK 通路的激活。